NL7305242A - - Google Patents

Info

Publication number
NL7305242A
NL7305242A NL7305242A NL7305242A NL7305242A NL 7305242 A NL7305242 A NL 7305242A NL 7305242 A NL7305242 A NL 7305242A NL 7305242 A NL7305242 A NL 7305242A NL 7305242 A NL7305242 A NL 7305242A
Authority
NL
Netherlands
Application number
NL7305242A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of NL7305242A publication Critical patent/NL7305242A/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D495/00Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D217/00Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/22Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the nitrogen-containing ring

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
NL7305242A 1972-04-13 1973-04-13 NL7305242A (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB1703372A GB1379111A (en) 1972-04-13 1972-04-13 Preparation of fused-ring pyridine and pyrazine derivatives

Publications (1)

Publication Number Publication Date
NL7305242A true NL7305242A (de) 1973-10-16

Family

ID=10088039

Family Applications (1)

Application Number Title Priority Date Filing Date
NL7305242A NL7305242A (de) 1972-04-13 1973-04-13

Country Status (9)

Country Link
US (1) US3895014A (de)
AU (1) AU5440173A (de)
BE (1) BE798122A (de)
DE (1) DE2318399A1 (de)
FR (1) FR2180066A1 (de)
GB (1) GB1379111A (de)
IE (1) IE37478B1 (de)
NL (1) NL7305242A (de)
ZA (1) ZA732230B (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SK134698A3 (en) * 1996-04-13 1999-06-11 Astra Pharma Prod Aminoisoquinolines and aminothienopyridine derivatives and their use as anti-inflammatory agents
US6291425B1 (en) 1999-09-01 2001-09-18 Guilford Pharmaceuticals Inc. Compounds, methods and pharmaceutical compositions for treating cellular damage, such as neural or cardiovascular tissue damage
US6635642B1 (en) 1997-09-03 2003-10-21 Guilford Pharmaceuticals Inc. PARP inhibitors, pharmaceutical compositions comprising same, and methods of using same
US6426415B1 (en) 1997-09-03 2002-07-30 Guilford Pharmaceuticals Inc. Alkoxy-substituted compounds, methods and compositions for inhibiting parp activity
US6514983B1 (en) 1997-09-03 2003-02-04 Guilford Pharmaceuticals Inc. Compounds, methods and pharmaceutical compositions for treating neural or cardiovascular tissue damage
US20020028813A1 (en) * 1997-09-03 2002-03-07 Paul F. Jackson Thioalkyl compounds, methods, and compositions for inhibiting parp activity
US6346536B1 (en) 1997-09-03 2002-02-12 Guilford Pharmaceuticals Inc. Poly(ADP-ribose) polymerase inhibitors and method for treating neural or cardiovascular tissue damage using the same
US6197785B1 (en) 1997-09-03 2001-03-06 Guilford Pharmaceuticals Inc. Alkoxy-substituted compounds, methods, and compositions for inhibiting PARP activity
US6395749B1 (en) 1998-05-15 2002-05-28 Guilford Pharmaceuticals Inc. Carboxamide compounds, methods, and compositions for inhibiting PARP activity
US6387902B1 (en) 1998-12-31 2002-05-14 Guilford Pharmaceuticals, Inc. Phenazine compounds, methods and pharmaceutical compositions for inhibiting PARP
WO2001090077A1 (en) 2000-05-19 2001-11-29 Guilford Pharmaceuticals, Inc. Sulfonamide and carbamide derivatives of 6(5h)phenanthridinones and their uses
US6348475B1 (en) 2000-06-01 2002-02-19 Guilford Pharmaceuticals Inc. Methods, compounds and compositions for treating gout

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1250828B (de) * 1962-10-10 1967-09-28 Chinoin Gyogyszer es Vegyeszeti Termekek Gyära R.T., Budapest Verfahren zur Herstellung des spasmolytisch wirksamen 6,7,3',4' - Tetraäthoxy -l-benzyliden-1,2,3,4tetrahydroisochinolins und seiner Salze
FR2028672A6 (de) * 1968-03-06 1970-10-16 Rhone Poulenc Sa
GB1244501A (en) * 1968-03-09 1971-09-02 Aspro Nicholas Ltd Heterocyclic amines

Also Published As

Publication number Publication date
DE2318399A1 (de) 1973-10-18
IE37478B1 (en) 1977-08-03
ZA732230B (en) 1974-11-27
BE798122A (fr) 1973-07-31
AU5440173A (en) 1974-10-17
GB1379111A (en) 1975-01-02
US3895014A (en) 1975-07-15
IE37478L (en) 1973-10-13
FR2180066A1 (de) 1973-11-23

Similar Documents

Publication Publication Date Title
CS152184B1 (de)
CS152722B1 (de)
CS152733B1 (de)
CS152940B1 (de)
CS152982B2 (de)
CS153284B1 (de)
CH567871A5 (de)
CH568742A5 (de)
CH559313A5 (de)
CH559322A5 (de)
CH559392A5 (de)
CH559529A5 (de)
CH559643A5 (de)
CH559905A5 (de)
CH560134A5 (de)
CH560355A5 (de)
CH563476A5 (de)
CH563754A5 (de)
CH564180A5 (de)
CH564480A5 (de)
CH564568A5 (de)
CH565586A5 (de)
CH565883A5 (de)
CH567864A5 (de)
CH574543A5 (de)